Tyrosine Kinase/Adaptors
Tyrosine kinase and adaptor inhibitors are compounds that target tyrosine kinases and their associated adaptor proteins, which play pivotal roles in cell signaling, growth, and differentiation. These inhibitors are essential tools in cancer research, as many tyrosine kinases are involved in the signaling pathways that drive tumor growth and metastasis. By inhibiting tyrosine kinases, these compounds can block critical signaling cascades, offering potential therapeutic strategies for various cancers and other diseases involving abnormal cell signaling. At CymitQuimica, we provide a comprehensive range of high-quality tyrosine kinase and adaptor inhibitors to support your research in oncology, molecular biology, and targeted therapy development.
Read more
Subcategories of "Tyrosine Kinase/Adaptors"
ALK
CSF-1R
EGFR
Ephrin Receptor
FLT
Fibroblast Growth Factor Receptor (FGFR)
HER
Hck
IGF-1R
PDGFR
PYK2
Src
TAM Receptor
Tie-2
Trk receptor
Tyrosine Kinases
VEGFR
c-Fms
c-Kit
c-Met/HGFR
c-RET
Show 13 more subcategories
Products of "Tyrosine Kinase/Adaptors"
KB SRC 4
CAS:1380088-03-8
KB SRC 4 is a selective and potent c-Src inhibitor with antitumour activity that inhibits …
Formula:
C32H23ClN8
Purity:
99.66% - 99.66%
Color and Shape:
Solid
Molecular weight:
555.03
Ref: TM-T11745
| 1mg | 147.00 € |
Estimated delivery in United States, on Monday 10 Feb 2025
Canlitinib
CAS:2222730-78-9
Canlitinib, a tyrosine kinase inhibitor, holds potential for cancer research.
Formula:
C33H31F2N3O7
Purity:
98%
Color and Shape:
Liquid
Molecular weight:
619.61
Ref: TM-T78206
| 5mg | To inquire | ||
| 50mg | To inquire |
Estimated delivery in United States, on Monday 10 Feb 2025
BGB-8035
CAS:2283349-24-4
BGB-8035 is a BTK inhibitor with antitumor activity that inhibits BTK, TEC, and EGFR.BGB-8035 is …
Formula:
C24H31N5O4
Purity:
96.74%
Color and Shape:
Liquid
Molecular weight:
453.53
Ref: TM-T73381
| 1mg | 384.00 € | ||
| 5mg | 911.00 € | ||
| 10mg | 1,225.00 € | ||
| 25mg | 1,828.00 € | ||
| 50mg | 2,394.00 € | ||
| 100mg | 3,154.00 € |
Estimated delivery in United States, on Monday 10 Feb 2025
YS-363
CAS:2470908-90-6
YS-363 is a potent, selective, and orally active inhibitor of the epidermal growth factor receptor …
Formula:
C30H30N4O3
Purity:
98%
Color and Shape:
Liquid
Molecular weight:
494.58
Ref: TM-T80748
| 5mg | To inquire | ||
| 50mg | To inquire |
Estimated delivery in United States, on Monday 10 Feb 2025
FGFR4-IN-16
CAS:1970120-44-5
FGFR4-IN-16 (CY-15-2) is a covalent inhibitor targeting FGFR-4, utilized in cancer research [1].
Formula:
C35H30Cl2N6O5
Purity:
98%
Color and Shape:
Liquid
Molecular weight:
685.56
Ref: TM-T79880
| 5mg | To inquire | ||
| 50mg | To inquire |
Estimated delivery in United States, on Monday 10 Feb 2025
TrkB-IN-1
CAS:1609067-49-3
TrkB-IN-1 is a potent, orally active agonist of the TrkB receptor, with favorable pharmacokinetic (PK) …
Formula:
C19H16N2O6
Purity:
98%
Color and Shape:
Liquid
Molecular weight:
368.34
Ref: TM-T79011
| 5mg | To inquire | ||
| 50mg | To inquire |
Estimated delivery in United States, on Monday 10 Feb 2025
Brepocitinib
CAS:1883299-62-4
Brepocitinib (PF-06700841) is a potent dual JAK1/TYK2 inhibitor (IC50s: 17 nM/23 nM). Brepocitinib also inhibits …
Formula:
C18H21F2N7O
Purity:
98%
Color and Shape:
Solid
Molecular weight:
389.4
Ref: TM-TQ0010
| 1mg | 35.00 € | ||
| 5mg | 69.00 € | ||
| 10mg | 102.00 € | ||
| 25mg | 212.00 € | ||
| 50mg | 383.00 € | ||
| 100mg | 614.00 € | ||
| 200mg | 859.00 € | ||
| 500mg | 1,270.00 € | ||
| 1mL*10mM (DMSO) | 117.00 € |
Estimated delivery in United States, on Monday 10 Feb 2025
BTK-IN-27
CAS:1841502-36-0
BTK-IN-27 (example 8), a potent BTK inhibitor with an IC50 of 0.2 nM, demonstrates anti-proliferative …
Formula:
C31H35N7O2
Purity:
98%
Color and Shape:
Liquid
Molecular weight:
537.66
Ref: TM-T79812
| 5mg | To inquire | ||
| 50mg | To inquire |
Estimated delivery in United States, on Monday 10 Feb 2025
TRK-IN-24
CAS:2937544-01-7
TRK-IN-24 (compound 10g) is a selective inhibitor of Trk receptors, effectively targeting TRKA, TRKC, and …
Formula:
C39H45N7O3
Purity:
98%
Color and Shape:
Liquid
Molecular weight:
659.82
Ref: TM-T79706
| 5mg | To inquire | ||
| 50mg | To inquire |
Estimated delivery in United States, on Monday 10 Feb 2025
Brolucizumab
CAS:1531589-13-5
Brolucizumab (DLX1008) is a single-chain anti-VEGF-A antibody fragment exhibiting low picomolar affinity (K D = …
Purity:
98%
Color and Shape:
Liquid
Ref: TM-T80593
| 1mg | 233.00 € | ||
| 5mg | 607.00 € | ||
| 10mg | 928.00 € | ||
| 25mg | 1,439.00 € | ||
| 50mg | 1,862.00 € | ||
| 100mg | 2,623.00 € |
Estimated delivery in United States, on Monday 10 Feb 2025
VEGFR-2-IN-37
CAS:298207-77-9
VEGFR-2-IN-37 (compound 12), a VEGFR-2 inhibitor, exhibits an inhibition rate of approximately 56.9 μM at …
Formula:
C18H16N2O2S
Purity:
98%
Color and Shape:
Liquid
Molecular weight:
324.4
Ref: TM-T80872
| 5mg | To inquire | ||
| 50mg | To inquire |
Estimated delivery in United States, on Monday 10 Feb 2025
CH6953755
CAS:2055918-71-1
CH6953755: oral YES1 kinase inhibitor, IC50 1.8 nM, potent, selective, anticancer, halts cell proliferation.
Formula:
C26H22F2N6O4S
Purity:
98.03%
Color and Shape:
Solid
Molecular weight:
552.55
Ref: TM-T10784
| 1mg | 57.00 € | ||
| 5mg | 121.00 € | ||
| 10mg | 184.00 € | ||
| 25mg | 359.00 € | ||
| 50mg | 576.00 € | ||
| 100mg | 924.00 € | ||
| 1mL*10mM (DMSO) | 149.00 € |
Estimated delivery in United States, on Monday 10 Feb 2025
EGFR-IN-87
CAS:1835666-87-9
EGFR-IN-87 is an EGFR tyrosine kinase inhibitor with potent inhibitory activity, exhibiting IC50 values of …
Formula:
C28H33N7O2
Purity:
98.3%
Color and Shape:
Liquid
Molecular weight:
499.61
Ref: TM-T79888
| 1mg | 182.00 € | ||
| 5mg | 450.00 € | ||
| 10mg | 645.00 € | ||
| 25mg | 1,007.00 € | ||
| 50mg | 1,388.00 € | ||
| 100mg | 1,836.00 € |
Estimated delivery in United States, on Monday 10 Feb 2025
Irpagratinib
CAS:2230974-62-4
Irpagratinib (ABSK011) is an orally active fibroblast growth factor receptor (FGFR) tyrosine kinase inhibitor with …
Formula:
C28H32F2N6O5
Purity:
98%
Color and Shape:
Liquid
Molecular weight:
570.59
Ref: TM-T79850
| 5mg | To inquire | ||
| 50mg | To inquire |
Estimated delivery in United States, on Monday 10 Feb 2025
BT424
CAS:2755180-37-9
BT424, a specific HCK inhibitor, modulates macrophage activation and autophagy in vitro, and mitigates inflammation …
Formula:
C22H15BCl2N2O2
Purity:
98%
Color and Shape:
Liquid
Molecular weight:
421.08
Ref: TM-T79516
| 5mg | To inquire | ||
| 50mg | To inquire |
Estimated delivery in United States, on Monday 10 Feb 2025
TL02-59
CAS:1315330-17-6
TL02-59: Fgr inhibitor (IC50=0.03nM), also targets Lyn (0.1nM), Hck (160nM), halts acute myelogenous leukemia growth.
Formula:
C32H34F3N5O4
Purity:
95.63%
Color and Shape:
Solid
Molecular weight:
609.64
Ref: TM-T13186
| 1mg | 69.00 € | ||
| 5mg | 130.00 € | ||
| 10mg | 205.00 € | ||
| 25mg | 346.00 € | ||
| 50mg | 493.00 € | ||
| 100mg | 671.00 € | ||
| 200mg | 903.00 € | ||
| 1mL*10mM (DMSO) | 169.00 € |
Estimated delivery in United States, on Monday 10 Feb 2025
Cinsebrutinib
CAS:2724962-58-5
Cinsebrutinib, a Bruton's tyrosine kinase inhibitor, holds potential for research in cancer treatment.
Formula:
C22H26FN3O2
Purity:
98%
Color and Shape:
Liquid
Molecular weight:
383.46
Ref: TM-T79841
| 5mg | To inquire | ||
| 50mg | To inquire |
Estimated delivery in United States, on Monday 10 Feb 2025
Tyrphostin AG 538
CAS:133550-18-2
Tyrphostin AG 538 is a chalcone compound, an IGF-1 receptor kinase inhibitor (IC₅0 : for …
Formula:
C16H11NO5
Purity:
99.73%
Color and Shape:
Soild
Molecular weight:
297.26
Ref: TM-T67707
| 1mg | 96.00 € | ||
| 5mg | 229.00 € | ||
| 10mg | 344.00 € | ||
| 25mg | 604.00 € | ||
| 50mg | 825.00 € | ||
| 100mg | 1,091.00 € |
Estimated delivery in United States, on Monday 10 Feb 2025
JDB175
CAS:2635328-79-7
JDB175, a selective BTK inhibitor with oral bioavailability, demonstrates excellent penetration through the blood-brain barrier.
Formula:
C26H21F3N4O2
Purity:
98%
Color and Shape:
Liquid
Molecular weight:
478.47
Ref: TM-T82010
| 5mg | To inquire | ||
| 50mg | To inquire |
Estimated delivery in United States, on Monday 10 Feb 2025
Terevalefim
CAS:1070881-42-3
Terevalefim (ANG-3777) is an hepatocyte growth factor (HGF) mimetic. Terevalefim selectively activates the c-Met receptor.
Formula:
C9H8N2S
Purity:
99.53%
Color and Shape:
Solid
Molecular weight:
176.24
Ref: TM-T37596
| 1mg | 55.00 € | ||
| 5mg | 118.00 € | ||
| 10mg | 207.00 € | ||
| 25mg | 360.00 € | ||
| 50mg | 529.00 € | ||
| 100mg | 737.00 € | ||
| 500mg | 1,504.00 € | ||
| 1mL*10mM (DMSO) | 119.00 € |
Estimated delivery in United States, on Monday 10 Feb 2025
